Table 3 Summary characteristics of full sample respondents (n = 59*) and respondents defining the factors
Full Sample | Defining Sorts | |||||
|---|---|---|---|---|---|---|
N | % | F1 (n = 19**) | F2 (n = 15**) | F3 (n = 16) | ||
Age | 18 - 30 | 4 | 7% | 1 | 1 | 1 |
31 - 50 | 31 | 53% | 8 | 6 | 10 | |
51 - 64 | 17 | 29% | 8 | 5 | 2 | |
65+ | 5 | 9% | 1 | 2 | 2 | |
Not stated | 2 | 3% | 0 | 0 | 1 | |
Gender | Female | 35 | 59% | 11 | 10 | 7 |
Male | 24 | 41% | 7 | 4 | 9 | |
Expertise | NHS | 22 | 36% | 8 | 6 | 5 |
Academic | 14 | 24% | 3 | 0 | 8 | |
Pharmaceutical Industry | 6 | 10% | 1 | 1 | 2 | |
Religion | 5 | 8% | 1 | 3 | 0 | |
Patient Groups (e.g. Cancer charities) | 3 | 5% | 1 | 1 | 0 | |
Journalist | 3 | 5% | 2 | 1 | 0 | |
Politician | 1 | 2% | 1 | 0 | 0 | |
Personal experience of terminal illness and/or bereavement | 5 | 8% | 1 | 2 | 1 | |
Experience of Terminal Illness (all respondents)*** | Cancer | 30 | 10 | 10 | 5 | |
Other terminal illness | 23 | 8 | 8 | 4 | ||
No | 16 | 4 | 1 | 8 | ||
Unstated | 1 | 0 | 0 | 0 | ||